4.5 Article

Transient receptor potential genes, smoking, occupational exposures and cough in adults

Journal

RESPIRATORY RESEARCH
Volume 13, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1465-9921-13-26

Keywords

Asthma; Gene-environment interaction; Irritant exposure; Smoking; TRP channel

Funding

  1. INSERM
  2. French Agency for Environmental and Occupational Health Safety [AFSSET-APR-SE-2004]
  3. French National Agency for Research [ANR 05-SEST-020-02/05-9-97, ANR 06-CEBS, ANR 10-PRSP]
  4. Merck Sharp Dohme (MSD)
  5. European Commission
  6. Albacete - Fondo de Investigaciones Santarias [97/0035-01, 13 99/0034-01, 99/0034-02]
  7. Hospital Universitario de Albacete, Consejeria de Sanidad
  8. Antwerp - FWO
  9. Flanders Belgium [G.0402.00]
  10. University of Antwerp
  11. Flemish Health Ministry
  12. Barcelona - Fondo de Investigaciones Sanitarias [99/0034-02, 99/0034-01]
  13. Red Respira [RTIC 03/11 ISC IIF]
  14. Deutsche Forschungsgemeinschaft (DFG) [FR 1526/1-1, MA 711/4-1]
  15. Galdakao - Basque Health Department
  16. Gothenburg - Swedish Heart Lung Foundation
  17. Swedish Foundation for Health Care Sciences & Allergy Research
  18. Swedish Asthma & Allergy Foundation
  19. Swedish Cancer & Allergy Foundation
  20. Grenoble - Programme Hospitalier de Recherche Clinique-DRC de Grenoble [2610]
  21. Ministry of Health, Directionde la Recherche Clinique
  22. Ministere de l'Emploi et de la Solidarite
  23. Direction Generale de la Sante
  24. CHU de Grenoble
  25. Comite des Maladies Respiratoires de l'Isere
  26. Hamburg - GSF-National Research Centre for Environment Health
  27. Ipswich and Norwich - Asthma UK
  28. Huelva - Fondo de Investigaciones Sanitarias (FIS) [97/0035-01, 99/003401, 99/003402]
  29. Montpellier - Programme Hospitalier de Recherche Clinique-DRC de Grenoble [2610]
  30. Ministry of Health, Direction de la Recherche Clinique
  31. Aventis (France)
  32. Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon
  33. Oviedo Fondo de Investigaciones Santarias (FIS) [97/0035-01, 99/0034-02, 99/0034-01]
  34. Paris - Ministere de l'Emploi et de la Solidarite
  35. UCBPharma (France)
  36. Glaxo France
  37. Programme Hospitalier de Recherche Clinique-DRC de Grenoble [2610]
  38. Ministry of Health
  39. Direction de la Recherche Clinique
  40. Tartu - Estonian Science Foundation
  41. Umea - Swedish Heart Lung Foundation
  42. Uppsala - Swedish Heart Lung Foundation
  43. GABRIEL
  44. European Community [01896, LSH-2004-1.2.5-1]
  45. Netherlands Organisation for Scientific Research (NWO)/French Ministry of foreign and European affairs
  46. CIBERESP
  47. ICREA Academia
  48. Spanish Ministry of Science and Innovation
  49. FEDER
  50. Plan E [SAF2009-09848]
  51. Generalitat de Catalunya [2009SGR-1369]
  52. ISCIII-RETIC [RD06/02]
  53. Marato TV3 [080430]
  54. European Academy of Allergology and Clinical Immunology-Global Allergy and Asthma European Network (EAACI-GA2LEN)
  55. Medical Research Council [G0801056B, G0901214] Funding Source: researchfish
  56. MRC [G0901214] Funding Source: UKRI

Ask authors/readers for more resources

Background: Transient receptor potential (TRP) vanilloid and ankyrin cation channels are activated by various noxious chemicals and may play an important role in the pathogenesis of cough. The aim was to study the influence of single nucleotide polymorphisms (SNPs) in TRP genes and irritant exposures on cough. Methods: Nocturnal, usual, and chronic cough, smoking, and job history were obtained by questionnaire in 844 asthmatic and 2046 non-asthmatic adults from the Epidemiological study on the Genetics and Environment of Asthma (EGEA) and the European Community Respiratory Health Survey (ECRHS). Occupational exposures to vapors, gases, dusts, and/or fumes were assessed by a job-exposure matrix. Fifty-eight tagging SNPs in TRPV1, TRPV4, and TRPA1 were tested under an additive model. Results: Statistically significant associations of 6 TRPV1 SNPs with cough symptoms were found in non-asthmatics after correction for multiple comparisons. Results were consistent across the eight countries examined. Haplotype-based association analysis confirmed the single SNP analyses for nocturnal cough (7-SNP haplotype: p-global = 4.8 x 10(-6)) and usual cough (9-SNP haplotype: p-global = 4.5 x 10(-6)). Cough symptoms were associated with exposure to irritants such as cigarette smoke and occupational exposures (p < 0.05). Four polymorphisms in TRPV1 further increased the risk of cough symptoms from irritant exposures in asthmatics and non-asthmatics (interaction p < 0.05). Conclusions: TRPV1 SNPs were associated with cough among subjects without asthma from two independent studies in eight European countries. TRPV1 SNPs may enhance susceptibility to cough in current smokers and in subjects with a history of workplace exposures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available